Naviscan's PEM Flex(TM) Scanner Shows Promising New Data in Breast Cancer Management

Naviscan PET Systems, Inc.. 2007 Dec 13

SAN ANTONIO, Dec. 13 /PRNewswire/ -- Naviscan PET Systems(R), a privately held company specializing in high resolution PET scanners, announced today at the San Antonio Breast Cancer Symposium -- new clinical data from a study using the PEM Flex scanner in breast cancer management.PEM Flex(TM) Solo II is a commercially available, FDA cleared high resolution PET scanner designed to image small body parts such as the breast and hand. Solo II utilizes PET technology for the breast application known as...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Editors' Choice

Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration